Literature DB >> 20190404

Effects of chronic treatment with honokiol in spontaneously hypertensive rats.

Gen-Shui Zhang1, Ru-Jun Wang, Hai-Ning Zhang, Gui-Ping Zhang, Miao-Shan Luo, Jian-Dong Luo.   

Abstract

The present study was performed to evaluate the antihypertensive effects of honokiol in vivo in spontaneously hypertensive rats (SHR). The effects of honokiol were investigated by determination of the blood pressure, vascular reactivity, oxidative parameters, and histologic change in the aorta. Long-term administration of honokiol (400 mg/kg/d) to SHR decreased systolic blood pressure significantly. Honokiol (200, 400 mg/kg/d) enhanced the aortic relaxation in response to acetylcholine after 49-d treatment, but had no significant effects on the relaxation to sodium nitroprusside. The oral administration of honokiol significantly increased the plasma level of NO(2(-))/NO(3(-)), but decreased the level of malondialdehyde in liver of SHR compared with the control vehicle. In addition, SHR administered honokiol showed significant reductions in the elastin bands and media thickness in the aorta. These results suggest that chronic treatment with honokiol exerts an antihypertensive effect in SHR, and its vasorelaxant action and antioxidant properties may contribute to reducing the elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190404     DOI: 10.1248/bpb.33.427

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  11 in total

1.  Hypertension and Mitochondrial Oxidative Stress Revisited: Sirtuin 3, the Improved "Antioxidant".

Authors:  Francis J Miller
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

2.  Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.

Authors:  Daniel Herrmann; Andrea Schreiber; Anna Ciotkowska; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Christian Gratzke; Martin Hennenberg
Journal:  Prostate Int       Date:  2014-08-26

3.  Local honokiol application inhibits intimal thickening in rabbits following carotid artery balloon injury.

Authors:  Yu Wang; Danyang Zhao; Jing Sheng; Ping Lu
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

4.  Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts.

Authors:  Lizhen Huang; Kailiang Zhang; Yingying Guo; Fengyuan Huang; Kevin Yang; Long Chen; Kai Huang; Fengxue Zhang; Qinqiang Long; Qinglin Yang
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

5.  Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress.

Authors:  Yuan Liu; Peng Cheng; An-Hua Wu
Journal:  Aging (Albany NY)       Date:  2020-05-04       Impact factor: 5.682

Review 6.  Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension.

Authors:  Sergey Dikalov; Anna Dikalova
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-01       Impact factor: 2.894

Review 7.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

8.  Protective effects of honokiol on ischemia/reperfusion injury of rat ovary: an experimental study.

Authors:  Senem Yaman Tunc; Elif Agacayak; Neval Yaman Goruk; Mehmet Sait Icen; Abdulkadir Turgut; Ulas Alabalik; Cihan Togrul; Cenap Ekinci; Aysun Ekinci; Talip Gul
Journal:  Drug Des Devel Ther       Date:  2016-03-08       Impact factor: 4.162

9.  Synergistic Antioxidant and Anti-Inflammatory Effects between Modified Citrus Pectin and Honokiol.

Authors:  Cheppail Ramachandran; Barry Wilk; Steven J Melnick; Isaac Eliaz
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-16       Impact factor: 2.629

10.  Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation.

Authors:  Pian-Pian Huang; Jun Fu; Li-Hua Liu; Ke-Fei Wu; Hong-Xia Liu; Ben-Ming Qi; Yun Liu; Ben-Ling Qi
Journal:  Int J Mol Med       Date:  2019-11-01       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.